SE9302006D0 - PROTEIN FORMULATION - Google Patents
PROTEIN FORMULATIONInfo
- Publication number
- SE9302006D0 SE9302006D0 SE9302006A SE9302006A SE9302006D0 SE 9302006 D0 SE9302006 D0 SE 9302006D0 SE 9302006 A SE9302006 A SE 9302006A SE 9302006 A SE9302006 A SE 9302006A SE 9302006 D0 SE9302006 D0 SE 9302006D0
- Authority
- SE
- Sweden
- Prior art keywords
- composition
- polysorbate
- stabilizing agent
- factor viii
- coagulation factor
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000001690 Factor VIII Human genes 0.000 abstract 2
- 108010054218 Factor VIII Proteins 0.000 abstract 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 229940105778 coagulation factor viii Drugs 0.000 abstract 2
- -1 polyhydroxyethylene Polymers 0.000 abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 229920001213 Polysorbate 20 Polymers 0.000 abstract 1
- 229920001400 block copolymer Polymers 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 229960002885 histidine Drugs 0.000 abstract 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 abstract 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 abstract 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 abstract 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract 1
- 229940068977 polysorbate 20 Drugs 0.000 abstract 1
- 229920000053 polysorbate 80 Polymers 0.000 abstract 1
- 229940068968 polysorbate 80 Drugs 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
FIELD: medicine. SUBSTANCE: invention relates to the new composition that involves coagulation factor VIII and nonionogenic surface-active substance, for example, block-copolymer, polyoxamer or ester of polyhydroxyethylene (20) derivative of sorbitol with fatty acid, for example, polysorbate-20 or polysorbate-80 as stabilizing agent. Composition can involve also sodium chloride, calcium chloride, L-histidine and/or sugars of sugar alcohols. Invention relates to the use of noninogenic surface-active substance as stabilizing agent in composition containing coagulation factor VIII also. EFFECT: new composition indicated above.
Priority Applications (28)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9302006A SE9302006D0 (en) | 1992-10-02 | 1993-06-11 | PROTEIN FORMULATION |
| EP93923080A EP0627924B1 (en) | 1992-10-02 | 1993-10-01 | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| DK93923080T DK0627924T3 (en) | 1992-10-02 | 1993-10-01 | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| EP06001883A EP1652534A3 (en) | 1992-10-02 | 1993-10-01 | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| MX9306133A MX9306133A (en) | 1992-10-02 | 1993-10-01 | COMPOSITION THAT INCLUDES A FORMULATION OF THE COAGULATION FACTOR VIII, PROCESS FOR ITS PREPARATION AND USE OF A SURFACTANT AS A STABILIZER. |
| EP99121997A EP1016673B1 (en) | 1992-10-02 | 1993-10-01 | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| ES93923080T ES2154650T3 (en) | 1992-10-02 | 1993-10-01 | COMPOSITION THAT INCLUDES A FORMULATION WITH COAGULATION FACTOR VIII, PROCEDURE FOR THE PREPARATION AND USE OF A TENSIOACTIVE AS A STABILIZER. |
| DE69329795T DE69329795T2 (en) | 1992-10-02 | 1993-10-01 | COMPOSITION CONTAINING COAGULATION FACTOR VIII; METHOD FOR THE PRODUCTION THEREOF AND THE USE OF A SURFACE-ACTIVE SUBSTANCE AS A STABILIZER |
| JP50895794A JP3905921B2 (en) | 1992-10-02 | 1993-10-01 | COMPOSITION CONTAINING COAGULATION FACTOR VIII, METHOD FOR PRODUCING THE SAME, AND METHOD FOR USING SURFACTANT AS STABILIATOR |
| DE69333974T DE69333974T2 (en) | 1992-10-02 | 1993-10-01 | Composition containing coagulation factor VIII; Process for their preparation and the use of a surfactant as stabilizer |
| CZ19941328A CZ290342B6 (en) | 1992-10-02 | 1993-10-01 | Storage-stable composition containing coagulation factor VIII and non-ionic surface-active substance and process for preparing thereof |
| AT99121997T ATE316981T1 (en) | 1992-10-02 | 1993-10-01 | COMPOSITION INCLUDING COAGULATION FACTOR VIII; METHOD FOR THE PRODUCTION THEREOF AND THE USE OF A SURFACE-ACTIVE SUBSTANCE AS A STABILIZER |
| PCT/SE1993/000793 WO1994007510A1 (en) | 1992-10-02 | 1993-10-01 | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| KR1019940701858A KR100303872B1 (en) | 1992-10-02 | 1993-10-01 | Compositions containing coagulation factor formulations, methods for their preparation and use of surfactants as stabilizers |
| CA002124690A CA2124690C (en) | 1992-10-02 | 1993-10-01 | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| AU52883/93A AU677797C (en) | 1992-10-02 | 1993-10-01 | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| AT93923080T ATE198277T1 (en) | 1992-10-02 | 1993-10-01 | COMPOSITION INCLUDING COAGULATION FACTOR VIII; METHOD FOR THE PRODUCTION THEREOF AND THE USE OF A SURFACE-ACTIVE SUBSTANCE AS A STABILIZER |
| HU9401382A HU220194B (en) | 1992-10-02 | 1993-10-01 | A composition and method for producing coagulation factor VIII |
| SK659-94A SK282483B6 (en) | 1992-10-02 | 1993-10-01 | Stable coagulation factor VIII composition, method for its preparation and stabilization |
| RU94032143A RU2136294C1 (en) | 1992-10-02 | 1993-10-01 | Composition containing preparation of clotting factor viii, method of its preparing and use of surface-active substance as stabilizing agent |
| NZ256921A NZ256921A (en) | 1992-10-02 | 1993-10-01 | Formulations of coagulation factor viii and a non-ionic surfactant and their preparation |
| US08/244,266 US5733873A (en) | 1992-10-02 | 1993-10-01 | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| PT93923080T PT627924E (en) | 1992-10-02 | 1993-10-01 | COMPOSITION FOR COMPOSITION OF THE COAGULATION FACTOR VIII PROCESS FOR PREPARING AND USING A STATICIZING STRENGTH AS A STABILIZER |
| FI942573A FI111443B (en) | 1992-10-02 | 1994-06-01 | Process for preparing a composition for stabilizing recombinant coagulation factor VIII |
| NO942033A NO942033D0 (en) | 1992-10-02 | 1994-06-01 | Preparation comprising coagulation factor VIII, method of preparation thereof and use of a surfactant as stabilizer |
| HU95P/P00473P HU211670A9 (en) | 1992-10-02 | 1995-06-28 | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| US08/863,198 US5919766A (en) | 1992-10-02 | 1997-05-27 | Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| GR20010400311T GR3035472T3 (en) | 1992-10-02 | 2001-02-23 | Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9202878A SE9202878D0 (en) | 1992-10-02 | 1992-10-02 | PROTEIN FORMULATION |
| SE9302006A SE9302006D0 (en) | 1992-10-02 | 1993-06-11 | PROTEIN FORMULATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9302006D0 true SE9302006D0 (en) | 1993-06-11 |
Family
ID=26661537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9302006A SE9302006D0 (en) | 1992-10-02 | 1993-06-11 | PROTEIN FORMULATION |
Country Status (2)
| Country | Link |
|---|---|
| RU (1) | RU2136294C1 (en) |
| SE (1) | SE9302006D0 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2921180B1 (en) * | 1999-02-22 | 2019-08-14 | University of Connecticut | Albumin-free factor VIII formulations |
| EP1359936B1 (en) * | 2001-02-05 | 2008-02-20 | Novo Nordisk Health Care AG | Combined use of factor vii polypeptides and factor viii polypeptides |
| US8399620B2 (en) * | 2007-07-11 | 2013-03-19 | Novo Nordisk A/S | Purification of factor VIII using a mixed-mode or multimodal resin |
| CN117860874B (en) * | 2024-03-12 | 2024-07-02 | 正大天晴药业集团南京顺欣制药有限公司 | Pharmaceutical composition of recombinant human coagulation factor VIIa |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4359463A (en) * | 1980-11-26 | 1982-11-16 | Rock Gail A | Stabilization of Factor VIII activity in whole blood or blood plasma |
| JPS5874617A (en) * | 1981-10-28 | 1983-05-06 | Green Cross Corp:The | Heat-treating method of aqueous solution containing blood coagulation factor 8 derived from human |
| DE4111393A1 (en) * | 1991-04-09 | 1992-10-15 | Behringwerke Ag | STABILIZED FACTOR VIII PREPARATIONS |
-
1993
- 1993-06-11 SE SE9302006A patent/SE9302006D0/en unknown
- 1993-10-01 RU RU94032143A patent/RU2136294C1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU94032143A (en) | 1996-08-20 |
| RU2136294C1 (en) | 1999-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2608762B2 (en) | Treatment for hyperhidrosis | |
| ES2154650T3 (en) | COMPOSITION THAT INCLUDES A FORMULATION WITH COAGULATION FACTOR VIII, PROCEDURE FOR THE PREPARATION AND USE OF A TENSIOACTIVE AS A STABILIZER. | |
| NO891379D0 (en) | ANESTHETIC SKIN MOISTURE PREPARATION AND PROCEDURE FOR PREPARING THEREOF. | |
| SE7903817L (en) | MORANOLIN DERIVATIVES | |
| ATE204178T1 (en) | METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN | |
| ES2153385T3 (en) | HUMAN GROWTH HORMONE BASED COMPOSITION. | |
| DE69414840D1 (en) | ACCEPTABLE PHARMACEUTICAL COMPOSITION CONTAINING AN ALCOHOL AND A HYDROPHALIC ACTIVE SUBSTANCE | |
| ES2102157T3 (en) | WATER EMULSION IN OIL FOR COSMETIC OR PHARMACEUTICAL USE. | |
| ATE177640T1 (en) | PHARMACEUTICAL COMPOSITION FOR WOUND, SCARS AND KELOID TREATMENT | |
| SE9401406D0 (en) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| JPH08208488A (en) | Skin preparation for external use | |
| UA41502C2 (en) | STABILIZED PHARMACEUTICAL PREPARATION CONTAINING GROWTH HORMONES AND HISTIDINS, GROWTH HORMYSTE CRYSTALS CONTAINING HISTIDINES AND THEIR METHOD | |
| KR870700599A (en) | Carboxylic acid derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses thereof | |
| DE58901002D1 (en) | AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES. | |
| ES460743A1 (en) | Preserving liquid antacid medicinal formulations | |
| PE33396A1 (en) | COMPOSITION FOR THE TREATMENT OF NICOTINE ANSIA AND / OR ABSTRACT SMOKING SYMPTOMS | |
| JP2844103B2 (en) | External preparation for skin | |
| NO306762B1 (en) | Use of lanolin derivatives in conjunction with polyethylene glycol ethers, their mixture and transdermal therapeutic system | |
| DE69401502D1 (en) | Pharmaceutical preparation for producing a stabilized powder which contains a combination of acetylsalicylic acid and metoclopramide as the active ingredient | |
| SE9302006D0 (en) | PROTEIN FORMULATION | |
| CS275816B6 (en) | Cosmetic preparation for use on greasy skin | |
| FR2358893A1 (en) | ANTIMICROBIAL COMPOSITION CONTAINING 1-IMIDAZOLYL-BUTANE-2-ONES OR -BUTANE-2-OLS HALOGENES | |
| TW328049B (en) | Penciclover/propylene glycol composition | |
| ES8200363A1 (en) | Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them. | |
| ATE91079T1 (en) | SALICYLIC ACID AGENT AGAINST SCALPING SKIN DISEASES. |